Germline BRCA1 pathogenic variants and T cell dysfunction.

Kay J, Harris MA, Lara Gonzalez LE, van Geelen CT, Clarke KA, Virassamy B, Caramia F, Pang JM, O'Malley MMR, Hun ML, Salgado R, Thorne H, Visvader J, Neeson PJ, Darcy PK, Loi S

Open source

DOI
10.1016/j.iotech.2026.101601
Published
2026 Sep
Container
Immuno-oncology technology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.iotech.2026.101601,
  title = {Germline BRCA1 pathogenic variants and T cell dysfunction.},
  author = {Kay J and Harris MA and Lara Gonzalez LE and van Geelen CT and Clarke KA and Virassamy B and Caramia F and Pang JM and O'Malley MMR and Hun ML and Salgado R and Thorne H and Visvader J and Neeson PJ and Darcy PK and Loi S},
  year = {2026},
  journal = {Immuno-oncology technology},
  doi = {10.1016/j.iotech.2026.101601},
  url = {https://doi.org/10.1016/j.iotech.2026.101601}
}

RIS

TY  - JOUR
TI  - Germline BRCA1 pathogenic variants and T cell dysfunction.
AU  - Kay J
AU  - Harris MA
AU  - Lara Gonzalez LE
AU  - van Geelen CT
AU  - Clarke KA
AU  - Virassamy B
AU  - Caramia F
AU  - Pang JM
AU  - O'Malley MMR
AU  - Hun ML
AU  - Salgado R
AU  - Thorne H
AU  - Visvader J
AU  - Neeson PJ
AU  - Darcy PK
AU  - Loi S
PY  - 2026
JO  - Immuno-oncology technology
DO  - 10.1016/j.iotech.2026.101601
UR  - https://doi.org/10.1016/j.iotech.2026.101601
ER  - 

APA

J, K., MA, H., LE, L. G., CT, V. G., KA, C., B, V., F, C., JM, P., MMR, O., ML, H., R, S., H, T., J, V., PJ, N., PK, D., & S, L. (2026). Germline BRCA1 pathogenic variants and T cell dysfunction.. Immuno-oncology technology. https://doi.org/10.1016/j.iotech.2026.101601

Source records